GLP-1 analogue medicines

This section brings together information and resources about GLP-1 medicines and tirzepatide, including how they work, how they are used in diabetes care, and what to expect when taking them. You’ll find guidance on GLP-1 receptor agonists, oral treatments such as Rybelsus, and information for people who are stopping GLP-1 medicines or tirzepatide. These resources are designed to help you better understand your treatment options and support you in managing your diabetes with confidence.

Diabetes and Steroid Tablets

This leaflet explains how steroids affect blood glucose levels, how to manage any changes in blood glucose levels and how to reduce and stop steroid treatment.

Non-insulin Medication (Tablets and Injectables)

This resource provides information on the various types of non-insulin tablets and injectables available to help you control your diabetes.

What are GLP-1 Analogues (Incretin Mimetics)?

GLP-1 Analogues, also known as Incretin Mimetics, are a class of medications that are commonly used to treat type 2 diabetes. This resource explains what they are, how they work and provides information for people taking them.

What are SGLT2 inhibitors?

SGLT2 inhibitors are a class of medications that are commonly used to treat type 2 diabetes. This resource explains what they are, how they work and provides information for people taking them.

What are Sulphonylureas?

Sulphonylureas are a class of medications that are commonly used to treat type 2 diabetes. This resource explains what they are, how they work and provides information for people taking them.

What is Metformin?

Metformin is one of the most commonly used medications for the treatment of type 2 diabetes. This resource explains what Metformin is, how it works and provides information for people taking it.

GLP-1 agonists

GLP-1 agonists (also known as GLP-1 analogues, GLP-1 RAs, incretin mimetics and non-insulin injectables)

Tirzepatide (Mounjaro)

Mounjaro (Tirzepatide )

Advice for stopping GLP-1 analogs or Tirzepatide (Mounjaro)

When GLP-1 agonists are stopped, it is common to experience increased hunger, changes in blood sugar levels, and possible weight regain. This guidance has been created to help you manage these changes, reduce the risk of weight regain, and maintain stable blood glucose levels after stopping treatment.